HGH - Human Growth Hormone - Doctor's Analysis of Side Effects & Properties

Key points from the talk (HGH / Human Growth Hormone)

What HGH is (and how it behaves in the body)

• HGH is described as a natural peptide secreted by the pituitary in men and women.
• It’s released in a pulsatile, circadian pattern and is influenced by:
  • Age
  • Sleep
  • Diet
  • Exercise
  • Medical conditions/disease states
  • Environmental + psychological states
• The body’s natural HGH is said to have a short half-life (10–20 minutes) versus pharmaceutical forms (4–5 hours).
• Most HGH effects are described as mediated through IGF-1 (insulin-like growth factor-1).

Testing & ethics (performance/drug use context)

• The speaker claims doping-test reliability is unreliable.
• Mentions testing out of season and notes “ethics” concerns, implying ongoing use and enforcement challenges.

Main legitimate medical uses (not bodybuilding)

• Children with short stature / growth delay (after pediatric endocrine evaluation)
• Pan-hypopituitarism (including cases with damaged pituitary/hypothalamus)
• Short bowel syndrome
• Severe chronic kidney disease

Benefits claimed in athletes / performance context (but with uncertainty)

• Fat loss / lipolysis (especially visceral fat, time- and person-dependent)
• Weak anabolic effects, including:
  • Muscle and bone/soft tissue effects (tendons/ligaments/collagen synthesis)
  • Use for recovery and strength post-surgery (citing surgical reports)
• Possible muscle cell growth mechanisms:
  • Hypertrophy
  • Satellite cell recruitment

Contradictions / mixed experiences

• A study is referenced as showing a paradoxical increase in tiredness/somnolence in some people.
• While anecdotes may report:
  • Focus
  • Improved cognition
  • More energy

Key risks & side effects discussed (wellness / safety takeaways)

Metabolic risks (biggest recurring theme)

• Potential to impair insulin signaling and raise glucose, increasing risk of diabetes.
• Heart/metabolic concerns highlighted:
  • Diabetes worsening
  • Possible heart changes (e.g., left ventricle enlargement)
  • Concern about endothelial plaque progression

Cancer concern (high uncertainty, but discussed)

• The speaker emphasizes no long-term data, but raises concern based on:
  • HGH increasing IGF-1
  • IGF-1 acting as a growth/cancer surrogate marker
• Anecdotal cases are mentioned (e.g., leukemia/lymphoma and various solid tumors), but causality is unknown.

Thyroid-related risk (rare/uncertain)

• Claims HGH may reduce conversion of T4 → T3 (active thyroid hormone) in a dose-dependent manner.
• Says thyroid-panel changes were rarely observed in checked patients.

Carpal tunnel / neuropathy

• Describes carpal tunnel syndrome risk as a metabolic effect affecting the median nerve (numbness in thumb and two fingers).
• Notes a strong anecdotal observation that symptoms can emerge after dosing.

Other stated risks

• Minimal to no withdrawal syndrome is claimed after stopping.
• Cost: potentially up to ~$4,000/month for long-term use.

Productivity / self-care “methodology” implied (harm-reduction stance)

The speaker doesn’t provide a structured lifestyle plan, but emphasizes decision-making and safety considerations:

• Conservative approach
  • Very conservative due to limited long-term evidence
• Prefer evidence-based management when needed
  • For testosterone deficiency: recommends testosterone replacement with expert oversight (citing more available data)
  • For HGH: emphasizes it’s “elusive” with no long-term double-blinded prospective studies expected soon
• Medical supervision is framed as essential
  • Especially when compared with safer, better-documented hormone replacement

Polypharmacy (what HGH is commonly stacked with) — and why it matters

The talk stresses that in real-world performance use, HGH is often combined with other drugs, increasing complexity and risk.

• Most common add-on: insulin
  • Rationale:
    • Combat insulin sensitivity impairment
    • Synergize with HGH for muscle anabolic effects (via IGF-1 receptor and IGF binding protein dynamics)
• Thyroid meds
  • T4/T3, with preference for T3 as the active form
• Anabolic steroids
  • Often used alongside HGH (claims of overlapping effects for body composition and muscle gain)
• Metformin
  • Mentioned for insulin sensitivity, but with concerns about:
    • Lactic acidosis
    • Renal issues
  • Includes a case report anecdote of unexplained muscle damage with steroids + HGH + metformin
• Gabapentin / pregabalin
  • Used to manage neuropathic symptoms (e.g., carpal-tunnel related pain/numbness)
• NSAIDs
  • Used over-the-counter for musculoskeletal achiness (joints/osteoarthritis/training wear)

Core caution: Combining multiple drugs is described as contributing to kidney/heart complications, especially with factors like protein + hypertension and bodybuilding-style workloads.

Presenter / source list

• Dr. Thomas O’Connor (speaker; referenced as “Dr. Thomas O’Connor here”)